Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Selling business ideas successfully requires strategic planning and effective communication. Explore actionable tips to enhance your selling skills.
17,500 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Claiming social security sounds like a safe move, but real life can flip the script. This guide breaks down the hidde...
Salesforce is a powerhouse, but big questions remain about margins and AI-driven pricing. This piece explains why I’m...
Crypto prediction markets are growing as traders bet on real-world outcomes. The space blends crypto tech with real e...
When a big holder trims a stake in a robotics and AI ETF, it sparks questions about conviction and risk. This guide b...
Rookie landlords often chase high rents and big cash flow. This guide explains what matters more than cash flow when ...
A single, powerful driver could unlock a dramatic March for Netflix. Learn the core monetization lever and what inves...
Solana nears a critical price threshold near the mid-$90s, sparking renewed bets on a rebound. Derivatives flow point...
A fresh survey stokes bubble fears around AI stocks. This guide breaks down what it could mean for your investments a...
BNO has jumped about 52% year-to-date, yet roll costs and futures contango are quietly eroding its gains. Here's what...
The beauty health (skin) 2025 landscape is reshaping portfolios. This guide breaks down earnings signals, growth engi...
Nebius’s stock surges latest after the company lands a Meta partnership valued at up to $27 billion, building on a re...